API Cefradine Powder Cas 38821-53-3 Stock Bulk 99% Cefradine / Cephradine

API Cefradine Powder Cas 38821-53-3 Stock Bulk 99% Cefradine / Cephradine

API Cefradine powder cas no. 38821-53-3 information:

Cefradine is the first generation of semisynthetic cephalosporin,antibacterial effect with Cephalexin is similar.

Cefradine can be taken orally,to absorb it well,higher concentration in the blood,characterized by β-lactamase resistance,against drug-resistant Staphylococcus aureus bacteria and other bacteria that are resistant to broad-spectrum antibiotics such as rapid and reliable bactericidal effect.

Cefradine mainly in the prototype by urinary excretion,high concentration in urine.Clinic for respiratory, urinary tract, skin and soft tissue infections, such as bronchitis,pneumonia,pyelonephritis,cystitis,such as ear,nose and throat infections,enteritis and diarrhea.

API Cefradine powder cas no. 38821-53-3 Function:

1.Antibacterial activity and cefalexin is similar.Cephradine clinic is mainly used for sensitive bacterial respiratory and urinary tract,skin and soft tissue infections,such as bronchitis,pneumonia,pyelonephritis, cystitis,such as ear,nose and throat infections,enteritis and diarrhea.

2.Cefradine is also often used to prevent postoperative infections.

3.Injections of arginine salt,heart,kidney dysfunction,this formulation is not easy to cause sodium retention.

API Cefradine powder cas no. 38821-53-3 Application:

1. in application the products Qian must detailed asked patients head spore bacteria pigment class, and penicillin class and the other drug allergy history, has penicillin class drug allergy sex shock history who not application the products, other patients caution with, application the products Shi must note head spore bacteria pigment class and penicillin class exists cross allergy reaction of opportunities about has 5%~10%, needed in closely observation Xia caution with. In case of an allergic reaction, stop using drugs. In case of anaphylactic shock, and immediately spot rescue, including maintaining a patent airway, oxygen and epinephrine, corticosteroid application.

2. the product is mainly passed out with kidney, renal impairment should be reduced dose or extend the delivery period.

3. this product can occur when copper sulfate method for the determination of glucose in urine of patients with false-positive reactions. Because the products can pass through the blood-placenta barrier into the fetal circulation, maternal drug use requires precise indications. The few can enter breast milk, although there is no lactating women report of the cephalosporin class, but still have to balance. Elderly patients with renal impairment, and should be appropriate to reduce the dose or extend the delivery period.

API Cefradine powder cas no. 38821-53-3 COA

Veterinary Drugs List

API Cefradine Powder Cas 38821-53-3 Stock Bulk 99% Cefradine / Cephradine